|
1
|
Qin ZJ: The research progress of
rheumatoid arthritis in diagnosis and treatment of Chinese and
western medicines. Acta Med Sin. 24:224–227. 2011.(In Chinese).
|
|
2
|
Fan FY and He XL: Research progress on
traditional Chinese medicine for rheumatoid arthritis. Journal of
Traditional Chinese Medicine University of Hunan. 26:60–61.
2006.(In Chinese).
|
|
3
|
Tong G, Zhang X, Tong W and Liu Y:
Association between polymorphism in STAT4 gene and risk of
rheumatoid arthritis: A meta-analysis. Hum Immunol. 74:586–592.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu J, Wang Q and Liu SY: Drug treatment of
rheumatoid arthritis. Chin Community Doctors. 17:22–23. 2002.(In
Chinese).
|
|
5
|
Niu LJ: Pharmacotherapy of rheumatoid
arthritis. Pain Clin J. 2:106–109. 2006.(In Chinese).
|
|
6
|
Li QX: Research progress on immune
mechanisms of traditional Chinese medicine for the treatment of
rheumatoid arthritis. Research of Traditional Chinese Medicine.
18:53–55. 2002.(In Chinese).
|
|
7
|
Huang MC, Pai FT, Lin CC, Chang CM, Chang
HH, Lee YC, Sun MF and Yen HR: Characteristics of traditional
Chinese medicine use in patients with rheumatoid arthritis in
Taiwan: A nationwide population-based study. J Ethnopharmacol.
176:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang JM, Tao QW, Zhang YZ, Xu Y and Yan
XP: Treating rheumatoid arthritis patients of Shen deficiency and
cold invading syndrome by bushen quhan zhiwang decoction combined
methotrexate: An evaluation of clinical efficacy and safety.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:614–618. 2013.(In Chinese).
PubMed/NCBI
|
|
9
|
Chen ZH: Clinical observation of Yishen
Zhuanggu Tongbi Decoction in the Treatment of rheumatoid arthritis.
Journal of Guangzhou University of Traditional Chinese Medicine.
22:19–22. 2005.(In Chinese).
|
|
10
|
Zhang YY, Chen JC, Qiu MS and Xu ZX:
Clinical Observation of Huatan Tongluo Fang in the treatment of
rheumatoid arthritis with phlegm-obstruction and blood-stasis Type.
Traditional Chinese Medicine Journal. 11:49–52. 2012.(In
Chinese).
|
|
11
|
Qiu MS, Chen JC, Zhang YY, Xu ZX, Jiang YF
and Peng YF: Effect of Huatan Tongluo Fang on collagen-induced
arthritis in rats. Journal of Beijing University of Traditional
Chinese Medicine. 35:121–124. 2012.(In Chinese).
|
|
12
|
Zheng CS, Ye HZ, Xu XJ and Liu XX:
Computational pharmacology study of tougu xiaotong granule in
preventing and treating knee osteoarthritis. Chin J Integr Med.
15:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH,
Huang SP and Liu XX: Computational approaches for exploring the
potential synergy and polypharmacology of Duhuo Jisheng Decoction
in the therapy of osteoarthritis. Mol Med Rep. 7:1812–1818.
2013.PubMed/NCBI
|
|
14
|
Shi SH, Cai YP, Cai XJ, Zheng XY, Cao DS,
Ye FQ and Xiang Z: A network pharmacology approach to understanding
the mechanisms of action of traditional medicine: Bushenhuoxue
formula for treatment of chronic kidney disease. PLoS One.
9:e891232014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao X, Hou T, Zhang W, Guo S and Xu X: A
3D structure database of components from Chinese traditional
medicinal herbs. J Chem Inf Comput Sci. 42:481–489. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou JJ, Xie GR and Yang JX: Handbook of
the Chemical Constituents in Chinese Herb Original Plants. Chemical
Industry Press. Beijing: 1165–1211. 2004.(In Chinese).
|
|
17
|
Wang ZQ: Research progress of chemical
composition and pharmacological effects of Rhizoma arisaematis.
Drug Evaluation Research. 32:144–149. 2009.(In Chinese).
|
|
18
|
Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH, Xu
HF and Liu XX: Network pharmacology-based prediction of the
multi-target capabilities of the compounds in Taohong Siwu
decoction and their application in osteoarthritis. Exp Ther Med.
6:125–132. 2013.PubMed/NCBI
|
|
19
|
Cheng SM, Wang HY, Li GY, Zhu Y, Zhao WB
and Wang JH: Research progress of Bombyx batryticatus. Journal of
Nongken Medicine. 34:443–448. 2012.(In Chinese).
|
|
20
|
Sheridan RP and Shpungin J: Calculating
similarities between biological activities in the MDL Drug Data
Report database. J Chem Inf Comput Sci. 44:727–740. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hassan M, Bielawski JP, Hempel JC and
Waldman M: Optimization and visualization of molecular diversity of
combinatorial libraries. Mol Divers. 2:64–74. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lipinski CA, Lombardo F, Dominy BW and
Feeney PJ: Experimental and computational approaches to estimate
solubility and permeability in drug discovery and development
settings. Adv Drug Deliv Rev. 46:3–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F,
Zhang L, Song Y, Liu X, Zhang J, et al: Therapeutic target database
update 2012: A resource for facilitating target-oriented drug
discovery. Nucleic Acids Res. 40:D1128–D1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hashimoto N, Iwasaki T, Kitano M, Ogata A
and Hamano T: Levels of vascular endothelial growth factor and
hepatocyte growth factor in sera of patients with rheumatic
diseases. Mod Rheumatol. 3:129–134. 2003. View Article : Google Scholar
|
|
25
|
Rose PW, Prlić A, Bi C, Bluhm WF, Christie
CH, Dutta S, Green RK, Goodsell DS, Westbrook JD, Woo J, et al: The
RCSB Protein Data Bank: Views of structural biology for basic and
applied research and education. Nucleic Acids Res. 43(D1):
D345–D356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Montes M, Braud E, Miteva MA, Goddard ML,
Mondésert O, Kolb S, Brun MP, Ducommun B, Garbay C and Villoutreix
BO: Receptor-based virtual ligand screening for the identification
of novel CDC25 phosphatase inhibitors. J Chem Inf Model.
48:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dobson CM: Chemical space and biology.
Nature. 432:824–828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tanaka Y: Current concepts in the
management of rheumatoid arthritis. Korean J Intern Med.
31:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang NN, Wang AW and Hao QX: New progress
of study on traditional Chinese medicine for the treatment of
rheumatoid arthritis. Modern Journal of Integrated Chinese
Traditional and Western Medicine. 20:2334–2336. 2011.(In
Chinese).
|
|
31
|
Zheng CE: The experience of research of
integrated traditional Chinese and Western medicine for the
treatment of rheumatoid arthritis. Integrated Traditional Chinese
and Western Medicine. 4:255–256. 2012.(In Chinese).
|
|
32
|
Wu YJ, Lao ZY and Zhang ZL: Clinical
observation on small doses Tripterygium wilfordii
polyglycoside combined with methotrexate in treating rheumatoid
arthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 21:895–896. 2001.(In
Chinese). PubMed/NCBI
|
|
33
|
Li YS, Yang JH, Fan SY and Zhang YY: The
experimental study of Tripterygium wilfordii polyglycoside
combination therapy with glycyrrhizic acid for rheumatoid arthritis
on efficacy enhancing and toxicity reducing. Chin J Tradit Med Sci
Technol. 15:2932008.(In Chinese).
|
|
34
|
Kitano H: A robustness-based approach to
systems-oriented drug design. Nat Rev Drug Discov. 6:202–210. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen M, Feng W, Cao H, Zou L, Chen C,
Baatrup A, Nielsen AB, Li H, Kassem M, Zou X and Bünger C: A
traditional Chinese medicine formula extracts stimulate
proliferation and inhibit mineralization of human mesenchymal stem
cells in vitro. J Ethnopharmacol. 125:75–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li XD, Huang Q and Xu XJ: Target-Li gand
space distribution of the compound sets from Xuefu Zhuyu Decoction,
a traditional chinese medicinal recipe. Acta Physico-Chimica
Sinica. 24:547–550. 2008.(In Chinese).
|
|
37
|
Ma JL, An LL and Xing X: Topology analysis
on urban public traffic networks. Journal of Shanxi Teachers
University. 23:51–55. 2009.(In Chinese).
|
|
38
|
Yang B, Qiu Y, Wang LP and Zhang XL:
Studies on the anti-inflammatory molecular mechanism of chlorogenic
acid extracted from Lonicera confusa DC in vitro. Chinese
Pharmacological Bulletin. 25:542–545. 2009.(In Chinese).
|
|
39
|
Huang JQ, Sun WJ, Wang SW and Zhu MZ:
Studies on the anti-inflammatory and antioxidant activity of
quercetin in rats with gouty arthritis. China Journal of Experiment
Traditional Medical Formulae. 18:169–173. 2012.(In Chinese).
|
|
40
|
Wang MY, Wei YF and Li XB: Chemical
constituents of antirheumatism fraction from Urtica fissa. Chinese
Traditional and Herbal Drugs. 37:1300–1303. 2006.(In Chinese).
|
|
41
|
Lv JZ and Deng JG: Research progress in
pharmacological effects of amygdalin. Drugs & Clinic.
27:530–535. 2012.(In Chinese).
|
|
42
|
He ZK and Shen JW: The value of MMP-2,
MMP-3, MMP-9 and TIMP-1 levels in the evaluation of knee joint
osteoarthritis. Chongqing Medical Journal. 42:3872–3874. 2013.(In
Chinese).
|
|
43
|
Wu ZB, Lu N, Wang YH, Shi ZG, Fan CM, Jia
J, Liu L, Leng N and Zhu P: Association of serum MMP-2 and MMP-9
and progression of joint damage in early rheumatoid arthritis.
Chinese Journal of Immunology. 22:260–262. 2006.(In Chinese).
|
|
44
|
Gao F, Chen LL, Yan SR, Guo SR, Zhao LH,
Yang P, Zhang CW and Ji XB: Correlation between serum levels of
MMP-1, MMP-9, TIMP-1, IL-6 and the severity of atherosclerotic
coronary artery disease. Journal of Clinical Research.
30:2384–2386. 2013.(In Chinese).
|
|
45
|
Royall J and Lyon B: Sea-change or change
challenge? Health information access in developing countries: The
U.S. National Library of Medicine experience. Afr Health Sci.
11:457–463. 2011.PubMed/NCBI
|
|
46
|
Zhou C, Qian L, Ma H, Yu X, Zhang Y, Qu W,
Zhang X and Xia W: Enhancement of amygdalin activated with
β-D-glucosidase on HepG2 cells proliferation and apoptosis.
Carbohydr Polym. 90:516–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
